Home/Filings/4/0001127602-22-013210
4//SEC Filing

Garay Arpa 4

Accession 0001127602-22-013210

CIK 0000310158other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:44 PM ET

Size

8.4 KB

Accession

0001127602-22-013210

Insider Transaction Report

Form 4
Period: 2022-05-03
Garay Arpa
SVP Human Health Global Mktg.
Transactions
  • Tax Payment

    Common Stock

    2022-05-03$87.65/sh221$19,3711,461 total
  • Exercise/Conversion

    Common Stock

    2022-05-03$87.65/sh+773$67,7531,682 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-05-037730 total
    From: 2020-05-03Exp: 2022-05-03Common Stock (773 underlying)
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]The restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installment on 5/3/2020, 5/3/2021 and 5/3/2022.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001916360

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:44 PM ET
Size
8.4 KB